Joint Pain Warning for Diabetes Meds
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
Diabetes Rx May Keep Arthritis at Bay
Call it a gut reaction. A popular diabetes medication works by helping gastrointestinal hormones that encourage insulin production. The same medication may also help ward off autoimmune diseases.
Adding Rx to Improve Blood Sugar
Many people with type 2 diabetes have to take long-acting insulin to keep blood sugar stable around the clock. Adding the medication linagliptin to the mix may improve results.
FDA Investigating Risk of Pancreatitis in Type 2 Diabetes Meds
The US Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.